Detalhe da pesquisa
1.
Analysis and enhancement of risk management for ethnic differences in antineoplastic drugs in Japan.
BMC Health Serv Res
; 22(1): 1292, 2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289504
2.
Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 1: efficacy endpoints and disease outcome assessments.
J Pediatr Gastroenterol Nutr
; 58(6): 679-83, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24866781
3.
Steps toward harmonization for clinical development of medicines in pediatric ulcerative colitis-a global scientific discussion, part 2: data extrapolation, trial design, and pharmacokinetics.
J Pediatr Gastroenterol Nutr
; 58(6): 684-8, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24866782
4.
Assessment of the impact of Japanese-specific long-term safety data on new drug approval.
Clin Transl Sci
; 14(6): 2339-2347, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34121342